Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 19,000 shares at $48.88 ($945K) on 2018-08-28, disclosed to the SEC on 2018-08-29.
Open-market sale of $945k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.11 | 10,000 | $501K | 53.0% |
| 2 | $48.88 | 5,000 | $244K | 25.9% |
| 3 | $49.79 | 4,000 | $199K | 21.1% |
| Total | $49.72 avg | 19,000 | $945K | 100% |
| Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |
| BSTC | SELL | 2015-06-25 | $1.9M | — | Filing → |